The estimated Net Worth of Amol Chaubal is at least $1.88 Миллион dollars as of 3 May 2021. Mr. Chaubal owns over 178 units of Quanterix Corp stock worth over $364,780 and over the last 6 years he sold QTRX stock worth over $175,194. In addition, he makes $1,343,420 as Chief Financial Officer at Quanterix Corp.
Amol has made over 13 trades of the Quanterix Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 178 units of QTRX stock worth $10,299 on 3 May 2021.
The largest trade he's ever made was selling 1,701 units of Quanterix Corp stock on 14 April 2020 worth over $36,027. On average, Amol trades about 169 units every 17 days since 2019. As of 3 May 2021 he still owns at least 30,222 units of Quanterix Corp stock.
You can see the complete history of Mr. Chaubal stock trades at the bottom of the page.
MR. Amol Chaubal serves as Chief Financial Officer of the Company. Prior to joining us, Mr. Chaubal served as the CFO of Global Operations at Smith & Nephew, a global medical devices company, from October 2017 to April 2019. Prior to his time at Smith & Nephew, he served as Corporate Vice President and Head of Finance for the Clinical Research Services business at Parexel from June 2015 to October 2017. Between May 2013 and May 2015, Mr. Chaubal served as CFO North America and Regional Chief Operating Officer at Brookfield Renewable Energy Group, which is part of Brookfield Asset Management. Prior to joining Brookfield, Mr. Chaubal was CFO North America at Novartis AG, where he spent 11 years in positions of increasing responsibility across Switzerland, Canada, and the United States. He has an M.B.A. (with distinction) from INSEAD (France). He began his career at Procter & Gamble Company after completing Masters degree in Chemical Engineering from the Indian Institute of Technology, Mumbai.
As the Chief Financial Officer of Quanterix Corp, the total compensation of Amol Chaubal at Quanterix Corp is $1,343,420. There are 2 executives at Quanterix Corp getting paid more, with E. Kevin Hrusovsky having the highest compensation of $3,631,000.
Amol Chaubal is 44, he's been the Chief Financial Officer of Quanterix Corp since 2019. There are 19 older and 2 younger executives at Quanterix Corp. The oldest executive at Quanterix Corp is Dr. David R. Walt Ph.D., 68, who is the Co-Founder, Chairman of Scientific Advisory Board & Independent Director.
Amol's mailing address filed with the SEC is 34, Maple Street, Milford, Worcester County, Massachusetts, 01757, United States.
Over the last 7 years, insiders at Quanterix Corp have traded over $25,118,881 worth of Quanterix Corp stock and bought 1,481,095 units worth $18,701,541 . The most active insiders traders include David R Walt, Paul M Meister и Keith Crandell. On average, Quanterix Corp executives and independent directors trade stock every 7 days with the average trade being worth of $100,483. The most recent stock trade was executed by Masoud Toloue on 13 August 2024, trading 19,000 units of QTRX stock currently worth $207,100.
quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).
Quanterix Corp executives and other stock owners filed with the SEC include: